Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market
Holding EVAX?
Track your performance easily

Evaxion Biotech (EVAX) Financial Statements

209 Followers

Evaxion Biotech Financial Overview

Evaxion Biotech's market cap is currently ―. The company's EPS TTM is $-2.908; its P/E ratio is -0.82; Evaxion Biotech is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -5.38M$ -4.72M$ -5.88M
EBITDA--$ -5.38M$ -4.72M$ -5.88M
Net Income Common Stockholders--$ -5.74M$ -4.77M$ -5.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.58M$ 13.18M$ 17.85M$ 25.25M$ 31.41M
Total Assets$ 12.89M$ 22.02M$ 27.45M$ 34.00M$ 41.08M
Total Debt$ 10.87M$ 10.26M$ 0.00$ 9.72M$ 10.29M
Net Debt$ 5.29M$ -2.93M$ -17.85M$ -15.54M$ -21.12M
Total Liabilities$ 17.62M$ 13.72M$ 13.90M$ 13.85M$ 14.69M
Stockholders Equity$ -4.73M$ -72.66M$ -65.76M$ 20.15M$ 26.39M
Cash Flow-
Free Cash Flow---$ -5.27M$ -8.37M
Operating Cash Flow---$ -5.19M$ -8.19M
Investing Cash Flow---$ -77.00K$ -159.00K
Financing Cash Flow---$ -300.00K$ 7.74M
Currency in USD

Evaxion Biotech Earnings and Revenue History

Evaxion Biotech Debt to Assets

Evaxion Biotech Cash Flow

Evaxion Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis